The centuries-old common law rule against unreasonable restraints on alienation of property discourages limitations on the free exchange or transfer of property as a brake on the efficient allocation of resources.

Pfizer Inc. will pay $450 million to settle a six-year lawsuit filed by Brigham Young University (BYU) over the development of the anti-inflammatory drug Celebrex, according to a regulatory filing Tuesday.